A single centre, open-label, randomised clinical trial to investigate Meningococcal serogroup A, C, W-135 and Y saccharide specific B cell response to a primary and a booster dose of the Meningococcal ACWY conjugate vaccine and to a primary dose of the ACWY polysaccharide vaccine followed by a booster dose of the Meningococcal ACWY conjugate vaccine administered to adult volunteers.

Trial Profile

A single centre, open-label, randomised clinical trial to investigate Meningococcal serogroup A, C, W-135 and Y saccharide specific B cell response to a primary and a booster dose of the Meningococcal ACWY conjugate vaccine and to a primary dose of the ACWY polysaccharide vaccine followed by a booster dose of the Meningococcal ACWY conjugate vaccine administered to adult volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2016

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Meningococcal vaccine groups A C Y W-135 polysaccharide
  • Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Jun 2012 Actual initiation date changed from 1 Jun 2009 to 27 Apr 2009 and official title amended as reported by European Clinical Trials Database.
    • 23 Oct 2011 Results assessing memory B-cell levels presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
    • 27 Oct 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top